Advances in the treatment of cervical cancer-Reference-Cited by-同舟云学术

Advances in the treatment of cervical cancer

Published:1998 Issue: Volume: Page:149-176
ISSN:0927-3042
Container-title:Gynecologic Oncology
language:
Short-container-title:

Author:

Moore David H.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-5447-9_4.pdf

Reference166 articles.

1. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.

2. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5–27.

3. Wingo PA, Bolden S, Tong T, Parker SL, Martin LM, Heath CW (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin 46:113–125.

4. Clark JG (1895) A more radical method of performing hysterectomy for cancer of the uterus. Johns Hopk Hosp Bull 52-53:120–128.

5. Mikuta JJ (1996) Historical development of radical surgery for cancer of the cervix. In: Rubin SC, Hoskins WJ, eds. Cervical Cancer and Preinvasive Neoplasia. New York: Lippincott-Raven, pp. 183–188.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer;Gynecologic Oncology;2024-04

2. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer;Gynecologic Oncology;2006-10

3. New developments in the treatment of invasive cervical cancer;Obstetrics and Gynecology Clinics of North America;2002-12